These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 894086)

  • 1. Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine.
    Wenzel RP; Craven RB; Davies JA; Hendley JO; Hamory BH; Gwaltney JM
    J Infect Dis; 1977 Aug; 136 Suppl():S204-7. PubMed ID: 894086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field trial of an inactivated Mycoplasma pneumoniae vaccine. I. Vaccine efficacy.
    Wenzel RP; Craven RB; Davies JA; Hendley JO; Hamory BH; Gwaltney JM
    J Infect Dis; 1976 Dec; 134(6):571-6. PubMed ID: 794422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population.
    Mogabgab WJ
    Am Rev Respir Dis; 1973 Oct; 108(4):899-908. PubMed ID: 4582435
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of inactivated Mycoplasma pneumoniae vaccine in man.
    Mogabgab WJ; Marchand S; Mills G; Beville R
    Dev Biol Stand; 1975; 28():597-608. PubMed ID: 1126587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplasma pneumoniae vaccine: antigenicity of buffered antigens in volunteers.
    Brown RC; Hendley JO; Gwaltney JM
    Infect Immun; 1972 May; 5(5):657-61. PubMed ID: 4637601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.
    Greenberg H; Helms CM; Grizzard MB; James WD; Horswood RL; Chanock RM
    Infect Immun; 1977 Apr; 16(1):88-92. PubMed ID: 873618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired immunity to Mycoplasma pneumoniae. Pneumonia in hamsters.
    Hayatsu E
    Microbiol Immunol; 1978; 22(4):181-95. PubMed ID: 692461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions--Systematic review and meta-analysis.
    Linchevski I; Klement E; Nir-Paz R
    Vaccine; 2009 Apr; 27(18):2437-46. PubMed ID: 19368785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection.
    Murphy D; Van Alstine WG; Clark LK; Albregts S; Knox K
    Am J Vet Res; 1993 Nov; 54(11):1874-80. PubMed ID: 8291766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiments to obtain and test vaccines against enzootic pneumonia in swine].
    Stoianov V
    Vet Med Nauki; 1976; 13(9):24-7. PubMed ID: 1025843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of inactive Mycoplasma pneumoniae vaccine in military personnel, 1964-1966.
    Mogabgab WJ
    Am Rev Respir Dis; 1968 Mar; 97(3):359-65. PubMed ID: 4867003
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental vaccination against Mycoplasma agalactiae using different inactivated vaccines.
    Tola S; Manunta D; Rocca S; Rocchigiani AM; Idini G; Angioi PP; Leori G
    Vaccine; 1999 Jul; 17(22):2764-8. PubMed ID: 10438045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of field studies using Stellamune mycoplasma vaccine in Luxembourg].
    Schoos J
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):43-50. PubMed ID: 9868832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of Mycoplasma pneumoniae polysaccharides.
    Brunner H
    Isr J Med Sci; 1981 Jul; 17(7):678-81. PubMed ID: 6793538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.
    Taylor G; Taylor-Robinson D
    Immunology; 1976 May; 30(5):611-8. PubMed ID: 1278933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of pre-existing antibody to subsequent infection by Mycoplasma pneumoniae in adults.
    McCormick DP; Wenzel RP; Senterfit LB; Beam WE
    Infect Immun; 1974 Jan; 9(1):53-9. PubMed ID: 4587385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of mycoplasmal lesions and clinical signs by vaccination against Mycoplasma hyorhinis.
    Lee JA; Hwang MA; Han JH; Cho EH; Lee JB; Park SY; Song CS; Choi IS; Lee SW
    Vet Immunol Immunopathol; 2018 Feb; 196():14-17. PubMed ID: 29695319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.
    Simberkoff MS; Cross AP; Al-Ibrahim M; Baltch AL; Geiseler PJ; Nadler J; Richmond AS; Smith RP; Schiffman G; Shepard DS
    N Engl J Med; 1986 Nov; 315(21):1318-27. PubMed ID: 3534568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine.
    Ross RF; Zimmermann-Erickson BJ; Young TF
    Am J Vet Res; 1984 Oct; 45(10):1899-905. PubMed ID: 6497088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated vaccine induces protection against Mycoplasma agalactiae infection in sheep.
    Greco G; Corrente M; Buonavoglia D; Aliberti A; Fasanella A
    New Microbiol; 2002 Jan; 25(1):17-20. PubMed ID: 11837386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.